Safety issues associated with using medication to treat overactive bladder.

about

Safety issues associated with using medication to treat overactive bladder.

Item

http://www.wikidata.org/entity/Q40058585

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Safety issues associated with using medication to treat overactive bladder.

@en

type

Item

label

Safety issues associated with using medication to treat overactive bladder.

@en

prefLabel

Safety issues associated with using medication to treat overactive bladder.

@en

P1476

Safety issues associated with using medication to treat overactive bladder.

@en

P2093

George Araklitis

http://www.w3.org/2001/XMLSchema#string

Linda Cardozo

http://www.w3.org/2001/XMLSchema#string

P2860

Intravesical OnabotulinumtoxinA Injection for Overactive Bladder Patients with Frailty, Medical Comorbidities or Prior Lower Urinary Tract Surgery

Cardiovascular Safety of β3-adrenoceptor Agonists for the Treatment of Patients with Overactive Bladder Syndrome

How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study

Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study

Vaginal administration of estradiol: effects of dose, preparation and timing on plasma estradiol levels.

Treatment of urogenital atrophy with low-dose estradiol: preliminary results.

Urinary retention in female OAB after intravesical Botox injection: who is really at risk?

Acetylcholine and delirium.

Effect of medications with anti-cholinergic properties on cognitive function, delirium, physical function and mortality: a systematic review.

OnabotulinumtoxinA 100U provides significant improvements in overactive bladder symptoms in patients with urinary incontinence regardless of the number of anticholinergic therapies used or reason for inadequate management of overactive bladder.

P304

1-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14740338.2017.1376646

http://www.w3.org/2001/XMLSchema#string

P407

English

P577

2017-09-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28889761

http://www.w3.org/2001/XMLSchema#string